Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.09 USD | +4.57% | 0.00% | +28.12% |
Business Summary
Number of employees: 154
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 17-01-02 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 19-12-01 |
Scott Macke
COO | Chief Operating Officer | - | 14-08-31 |
Jerad G. Seurer
CMP | Compliance Officer | - | 16-12-31 |
Jennifer Gudeman
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-06 |
Jason Vaughn
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-01 |
Denise Strauss
SAM | Sales & Marketing | - | 21-06-01 |
Angela Woods
HRO | Human Resources Officer | - | 21-04-30 |
Richard Kim
PRN | Corporate Officer/Principal | 54 | 21-02-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 18-11-30 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 17-01-02 |
Mark McCamish
BRD | Director/Board Member | 72 | 19-12-04 |
Geoffrey Glass
CHM | Chairman | 50 | 18-06-30 |
Linda Palczuk
BRD | Director/Board Member | 62 | 18-06-30 |
Peter Thornton
BRD | Director/Board Member | 59 | 17-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,576,998 | 86,139,858 ( 95.10 %) | 0 | 95.10 % |
Stock B | 0 | 5,194,000 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.12% | 1.64B | |
+27.92% | 672B | |
+27.68% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+6.30% | 217B | |
+4.80% | 199B | |
-6.05% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- AVDL Stock
- Company Avadel Pharmaceuticals plc